• Je něco špatně v tomto záznamu ?

Absence of pre-transplant T cell response against LAA is associated with Flt3-ITD mutation and increased relapse-risk in AML patients with HSCT

M. Šťastná-Marková, P. Hainz, J. Kryštofová, J. Macková, K. Roubalová, J. Vydra, Š. Němečková

. 2025 ; 17 (3) : 185-190. [pub] 20250318

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009969

AIMS: This study aimed to examine changes in the repertoire of functional T-cells specific for six leukemia-associated antigens (LAA), including WT1, PRAME, MUC1, CCNA1, NPM1, and NPM1c, during immune reconstitution following allogeneic transplantation of hematopoietic stem cells (HSCT) in patients with acute myeloid leukemia. PATIENTS & METHODS: LAA-specific T cell response was measured by ELISPOT- IFNγ and intracellular cytokine staining in 47 patients before starting conditioning therapy (baseline) and 7 months after HSCT. RESULTS: The positive cumulative LAA-specific T cell response before HSCT was associated with a decreased risk of relapse after HSCT. The prevalent genetic aberration - an internal tandem duplication of Fms 3 - related receptor tyrosine kinase, which has been previously implicated in immune escape mechanisms, is presented here for the first time as a factor associated with the absence of an adaptive T cell response against multiple LAAs. T-cell specific responses against wild-type and mutated NPM1 antigens were less frequent in the study cohort and did not correlate with mutations in the NPM1 gene. CONCLUSIONS: Our results showed that the T-cell response to LAA can be reconstituted after HSCT. Measurement of functional pre-transplant T-cell responses against multiple LAAs could help to find patients with an increased risk of relapse.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009969
003      
CZ-PrNML
005      
20250429135202.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/1750743X.2025.2478804 $2 doi
035    __
$a (PubMed)40099461
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šťastná-Marková, Markéta $u Transplantation and Intensive Care Unit, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Institute of Clinical and Experimental Hematology of the 1st Faculty of Medicine of Charles University, Prague, Czech Republic
245    10
$a Absence of pre-transplant T cell response against LAA is associated with Flt3-ITD mutation and increased relapse-risk in AML patients with HSCT / $c M. Šťastná-Marková, P. Hainz, J. Kryštofová, J. Macková, K. Roubalová, J. Vydra, Š. Němečková
520    9_
$a AIMS: This study aimed to examine changes in the repertoire of functional T-cells specific for six leukemia-associated antigens (LAA), including WT1, PRAME, MUC1, CCNA1, NPM1, and NPM1c, during immune reconstitution following allogeneic transplantation of hematopoietic stem cells (HSCT) in patients with acute myeloid leukemia. PATIENTS & METHODS: LAA-specific T cell response was measured by ELISPOT- IFNγ and intracellular cytokine staining in 47 patients before starting conditioning therapy (baseline) and 7 months after HSCT. RESULTS: The positive cumulative LAA-specific T cell response before HSCT was associated with a decreased risk of relapse after HSCT. The prevalent genetic aberration - an internal tandem duplication of Fms 3 - related receptor tyrosine kinase, which has been previously implicated in immune escape mechanisms, is presented here for the first time as a factor associated with the absence of an adaptive T cell response against multiple LAAs. T-cell specific responses against wild-type and mutated NPM1 antigens were less frequent in the study cohort and did not correlate with mutations in the NPM1 gene. CONCLUSIONS: Our results showed that the T-cell response to LAA can be reconstituted after HSCT. Measurement of functional pre-transplant T-cell responses against multiple LAAs could help to find patients with an increased risk of relapse.
650    _2
$a lidé $7 D006801
650    12
$a nukleofosmin $7 D000090243
650    12
$a transplantace hematopoetických kmenových buněk $7 D018380
650    12
$a akutní myeloidní leukemie $x terapie $x imunologie $x genetika $7 D015470
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a tyrosinkinasa 3 podobná fms $x genetika $7 D051941
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dospělí $7 D000328
650    12
$a T-lymfocyty $x imunologie $7 D013601
650    12
$a mutace $7 D009154
650    _2
$a antigeny nádorové $x imunologie $7 D000951
650    _2
$a recidiva $7 D012008
650    _2
$a senioři $7 D000368
650    _2
$a mladý dospělý $7 D055815
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    _2
$a mucin 1 $x genetika $x imunologie $7 D018396
650    _2
$a proteiny WT1 $x imunologie $x genetika $7 D025721
650    _2
$a homologní transplantace $7 D014184
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hainz, Petr $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Kryštofová, Jitka $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Macková, Jana $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Roubalová, Kateřina $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic
700    1_
$a Vydra, Jan $u Transplantation and Intensive Care Unit, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Institute of Clinical and Experimental Hematology of the 1st Faculty of Medicine of Charles University, Prague, Czech Republic
700    1_
$a Němečková, Šárka $u Department of Immunology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic $1 https://orcid.org/0000000160014007
773    0_
$w MED00175821 $t Immunotherapy $x 1750-7448 $g Roč. 17, č. 3 (2025), s. 185-190
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40099461 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135158 $b ABA008
999    __
$a ok $b bmc $g 2311377 $s 1247050
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 17 $c 3 $d 185-190 $e 20250318 $i 1750-7448 $m Immunotherapy $n Immunotherapy $x MED00175821
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...